Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Diabetes Research Institute's Alberto Pugliese, M.D. Receives The J. Enloe And Eugenia J. Dodson Chair In Diabetes Research

Diabetes Research Institute logo

News provided by

Diabetes Research Institute Foundation

Oct 18, 2016, 01:50 ET

Share this article

Share toX

Share this article

Share toX

MIAMI, Oct. 18, 2016 /PRNewswire-USNewswire/ -- Immune tolerance leader Alberto Pugliese, M.D., was presented with the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research during a ceremony at the Diabetes Research Institute (DiabetesResearch.org) on October 13, 2016.  Pugliese is a professor in the Department of Medicine/Division of Diabetes, Endocrinology and Metabolism, professor in the Department of Microbiology and Immunology, and Deputy Director for Immune Tolerance Research at the Diabetes Research Institute (DRI) at the University of Miami Leonard M. Miller School of Medicine.

At the ceremony for the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, speakers, including Bart Roep, M.D., Ph.D., Camillo Ricordi, M.D., Laurence B. Gardner, M.D., MACP, Alberto Pugliese, M.D., President Julio Frenk, and Joshua Rednik, pause for a photo, while Valentina Pugliese tries out her father's chair.
At the ceremony for the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, speakers, including Bart Roep, M.D., Ph.D., Camillo Ricordi, M.D., Laurence B. Gardner, M.D., MACP, Alberto Pugliese, M.D., President Julio Frenk, and Joshua Rednik, pause for a photo, while Valentina Pugliese tries out her father's chair.
Immune Tolerance Leader Alberto Pugliese, M.D. (center) of the Diabetes Research Institute with John Hughes and Lindsey Inserra-Hughes, in front of a plaque with a photo of the late Eugenia Dodson.  Dr. Pugliese's specialty was highlighted throughout the day during the Lindsey Inserra-Hughes Immune Tolerance Seminar Series and the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, which was held at the Diabetes Research Institute at the University of Miami Leonard M. Miller School of Medicine.
Immune Tolerance Leader Alberto Pugliese, M.D. (center) of the Diabetes Research Institute with John Hughes and Lindsey Inserra-Hughes, in front of a plaque with a photo of the late Eugenia Dodson. Dr. Pugliese's specialty was highlighted throughout the day during the Lindsey Inserra-Hughes Immune Tolerance Seminar Series and the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, which was held at the Diabetes Research Institute at the University of Miami Leonard M. Miller School of Medicine.
At the ceremony for the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, speakers, including Bart Roep, M.D., Ph.D., Camillo Ricordi, M.D., Laurence B. Gardner, M.D., MACP, Alberto Pugliese, M.D., President Julio Frenk, and Joshua Rednik, pause for a photo, while Valentina Pugliese tries out her father's chair. Immune Tolerance Leader Alberto Pugliese, M.D. (center) of the Diabetes Research Institute with John Hughes and Lindsey Inserra-Hughes, in front of a plaque with a photo of the late Eugenia Dodson.  Dr. Pugliese's specialty was highlighted throughout the day during the Lindsey Inserra-Hughes Immune Tolerance Seminar Series and the presentation of the J. Enloe and Eugenia J. Dodson Chair in Diabetes Research, which was held at the Diabetes Research Institute at the University of Miami Leonard M. Miller School of Medicine.

"Helping to cure and prevent type 1 diabetes through research has always been my career goal," Pugliese said to a packed room of friends, family, and colleagues. "I have been learning from all of you.  It's been a remarkable journey in knowledge, and it's helping us get closer to the solution."  After thanking his wife, daughter, and mother, who were in attendance, Pugliese poignantly dedicated the tribute to his late father.

>>Watch Pugliese's acceptance speech video

"To be awarded an endowed chair is a very high honor, and we could not be more pleased that it's being bestowed upon Dr. Alberto Pugliese," said Joshua W. Rednik, President and Chief Executive Officer of the Diabetes Research Institute Foundation (DRIF), the non-profit organization whose sole mission is to provide funding to the Diabetes Research Institute, and the University of Miami's largest overall donor.  "It's clear that Dr. Pugliese has the respect and admiration of his peers, within the DRI, and beyond its borders."

The DRIF endowed this chair as a result of a substantial $35.6 million gift from the estate of the late Mrs. Eugenia J. Dodson of Coral Gables.  Nearly $25 million was given to the DRIF, while Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine received the remaining funds.  In addition to the chair, the DRIF created the J. Enloe and Eugenia J. Dodson Diabetes Center for Translational Research at the DRI to help fund scientific initiatives in cutting-edge areas, including immune tolerance, which is Pugliese's area of specialty.

According to Donald E. Kubit, of Fowler White Burnett P.A. who served as her attorney and co-trustee of her revocable trust, Dodson lived a modest lifestyle because she had a higher purpose for her wealth.  After her husband's death, she invested her money and allowed the investments to grow into a small fortune over 50 years.

"Gene lived a truly selfless life so she could fulfill her philanthropic goals," said Kubit at the time the donation was given.  Kubit was instrumental in facilitating the gifts to the DRIF and Sylvester Comprehensive Cancer Center.  "Eugenia Dodson's final estate plan was consistent with her profound desire to fund research to find a cure for diabetes and cancer."

"Few stories are more inspiring than that of Mrs. Dodson.  Her support of the Diabetes Research Institute and the Sylvester Comprehensive Cancer Center has had a critical impact in cure-focused research into these debilitating diseases," said University of Miami President Julio Frenk.  "I am very pleased to be here as we celebrate the installation of a new chair holder, which is truly one of the most prestigious academic tributes in higher education."

"Alberto Pugliese is a connector.  He's always putting patients and a cure at the center of all decision-making.  Alberto is a remarkable individual," said Camillo Ricordi, M.D., Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, professor of biomedical engineering, microbiology, and immunology, and Director of the Diabetes Research Institute. Ricordi also thanked Pugliese for being a great "friend and collaborator."

Pugliese is dedicated to advancing type 1 diabetes research through scientific excellence, open collaboration, and the training of new investigators.  For the last 25 years, he has studied type 1 diabetes from the preclinical period to the clinical diagnosis, and afterwards, in the setting of transplantation. His research has provided seminal contributions in type 1 diabetes genetics, immunology, pathology, and clinical trials.  Since 2001, Pugliese has been a steering committee member of the Type 1 Diabetes TrialNet, a National Institutes of Health-funded clinical trial network, for which he has chaired several committees and initiatives. He is also Executive Co-Director of the JDRF Network for Pancreatic Organ Donors (nPOD), along with Mark Atkinson, Ph.D., American Diabetes Association Eminent Scholar for Diabetes Research and professor of the departments of Pathology and Pediatrics at the University of Florida.

The endowed chair will help support Pugliese and his research in the area of immune tolerance, which was spotlighted during the inaugural Lindsey Inserra-Hughes Immune Tolerance Seminar Series at the University of Miami Leonard M. Miller School of Medicine. Several leaders in the field were in attendance, including respected peers like Atkinson, Paul Bollyky, M.D., Ph.D., of Stanford University, Helena Reijonen, Ph.D., and Bart Roep, M.D., Ph.D., of the City of Hope in Los Angeles, and Thomas Malek, Ph.D., Ricordi, and Jay S. Skyler, M.D., of the DRI.  This event, along with the presentation of the chair, underscores the Diabetes Research Institute and Foundation's focus on the immunology/immune tolerance issues related to type 1 diabetes.  

As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. For more information, please visit DiabetesResearch.org or call 800-321-3437.

Photo - http://photos.prnewswire.com/prnh/20161018/429946
Photo - http://photos.prnewswire.com/prnh/20161018/429945
Logo - http://photos.prnewswire.com/prnh/20120405/DC83112LOGO

SOURCE Diabetes Research Institute Foundation

Related Links

http://www.diabetesresearch.org

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.